This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by George, F. W. Search for Related Content PubMed PubMed Citation Articles by George, F. W.

Androgen Metabolism in the Prostate of the Finasteride-Treated, Adult Rat: A Possible Explanation for the Differential Action of Testosterone and 5-Dihydrotestosterone during Development of the Male Urogenital Tract¹

Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75235-8857

Address all correspondence and requests for reprints to: F. W. George, Ph.D., Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8857. E-mail: george02{at}utsw.swmed.edu

Previous work has clearly demonstrated that inhibition of 5-dihydrotestosterone (DHT) formation in vivo is not as effective as total androgen ablation (castration) in causing involution of the prostate. It is likely that this is due to the fact that testosterone is partially effective in maintaining androgen action. To provide insight into this observation, the androgenic metabolites of testosterone, androstenedione, and 5-DHT, were measured in prostate tissue and in blood of 5-reductase inhibitor (finasteride)-treated adult male rats. Finasteride treatment caused a significant decrease in prostatic DHT levels and a profound increase in prostatic testosterone and androstenedione levels. Similarly, circulating DHT levels were decreased in finasteride-treated rats (0.02 ng/ml compared with 0.05 ng/ml seen in control rats), and circulating androstenedione and testosterone levels were significantly elevated in finasteride-treated animals compared with controls. The in vitro effects of finasteride were assessed on the metabolism of [³H]testosterone in a tissue-slice assays. In the prostate, the inhibition of 5-reductase activity resulted not only in the decreased formation of 5-reduced metabolites (primarily DHT and 5-androstanedione), but also an increase in the 17-oxo metabolite androstenedione. In contrast, the tissues derived from the embryonic wolffian duct (seminal vesicle and epididymis) formed relatively low amounts of 17-keto steroids. Because DHT is a high affinity ligand for the androgen receptor and androstenedione shows very little, if any, affinity for the receptor, these studies suggest that 5-reduction of testosterone may be a mechanism to amplify androgen action in urogenital tissues such as the prostate by preventing catabolism of testosterone to the inactive androgen, androstenedione, at the site of hormone action.

This article has been cited by other articles:

				R Urbatzka, B Watermann, I Lutz, and W Kloas Exposure of Xenopus laevis tadpoles to finasteride, an inhibitor of 5-{alpha} reductase activity, impairs spermatogenesis and alters hypophyseal feedback mechanisms J. Mol. Endocrinol., November 1, 2009; 43(5): 209 - 219. [Abstract] [Full Text] [PDF]

				L. K. Potter, M. G. Zager, and H. A. Barton Mathematical model for the androgenic regulation of the prostate in intact and castrated adult male rats Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E952 - E964. [Abstract] [Full Text] [PDF]

				S. E. Borst, J. H. Lee, and C. F. Conover Inhibition of 5{alpha}-reductase blocks prostate effects of testosterone without blocking anabolic effects Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E222 - E227. [Abstract] [Full Text] [PDF]

				W. Gao, J. D. Kearbey, V. A. Nair, K. Chung, A. F. Parlow, D. D. Miller, and J. T. Dalton Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5{alpha}-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia Endocrinology, December 1, 2004; 145(12): 5420 - 5428. [Abstract] [Full Text] [PDF]

				B. S. McIntyre, N. J. Barlow, and P. M. D. Foster Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues Toxicol. Sci., August 1, 2001; 62(2): 236 - 249. [Abstract] [Full Text] [PDF]

				S. Ohsako, Y. Miyabara, N. Nishimura, S. Kurosawa, M. Sakaue, R. Ishimura, M. Sato, K. Takeda, Y. Aoki, H. Sone, et al. Maternal Exposure to a Low Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Suppressed the Development of Reproductive Organs of Male Rats: Dose-Dependent Increase of mRNA Levels of 5{{alpha}}-Reductase Type 2 in Contrast to Decrease of Androgen Receptor in the Pubertal Ventral Prostate Toxicol. Sci., March 1, 2001; 60(1): 132 - 143. [Abstract] [Full Text] [PDF]

				T. S. Sperry and P. Thomas Characterization of Two Nuclear Androgen Receptors in Atlantic Croaker: Comparison of Their Biochemical Properties and Binding Specificities Endocrinology, April 1, 1999; 140(4): 1602 - 1611. [Abstract] [Full Text]

				V. A. Tobin and B. J. Canny The Regulation of Gonadotropin-Releasing Hormone-Induced Calcium Signals in Male Rat Gonadotrophs by Testosterone Is Mediated by Dihydrotestosterone Endocrinology, March 1, 1998; 139(3): 1038 - 1045. [Abstract] [Full Text] [PDF]